Pharmacia and Upjohn and Gilead sciences receive European recommendation for cidofovir.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000998:Antiviral Agents / Q000627:therapeutic use*; D000077404:Cidofovir; D017726:Cytomegalovirus Retinitis / Q000188:drug therapy*; D003596:Cytosine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004345:Drug Industry; D005060:Europe; D006801:Humans; D007262:Infusions, Intravenous; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D011358:Product Surveillance, Postmarketing
D000998:Antiviral Agents; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D003596:Cytosine; D000077404:Cidofovir